Australia's MedAdvisor hits nearly 8-month high on upbeat revenue forecast

Adheris Health

21/12/2022 01:08

** Shares of MedAdvisor Ltd  MDR.AX  rise as much as 24.4%
to A$0.28, their highest since April 26
    ** Medication technology co expects first half FY23 revenue
to be 50% to 60% higher on first half FY22  urn:newsml:reuters.com:*:nASXJN4gL
    ** Co expects revenue to be between A$58 mln ($38.77 mln)
and A$61 mln for first half FY23 
    ** Shares of co are down 43.0% YTD as of last close 
($1 = 1.4961 Australian dollars)
 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))